In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Solvay licenses Pronova Biocare's Omacor

Executive Summary

Solvay Pharmaceuticals (therapeutics within the areas of cardiology, gastroenterology, mental health, and hormone replacements) received a license to market Omacor, a cardiology product from Pronova Biocare (Omega-3 fatty acids), a business unit of Norsk Hydro's Hydro Pronova subsidiary.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register